Disease

Leukemia, Erythroblastic, Acute

Clinical development underwayEmerging research

MeSHLeukemia, Erythroblastic, Acute

Publications

Clinical trials

1985

Latest publication

Latest activity

beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Research1985-10-01Annals of internal medicine

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme

All trials

Active

Late-stage

Completed

Recently completed

Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission

Phase 2 · Completed · Weill Medical College of Cornell University

Research activity

1 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Most influential

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Annals of internal medicine · 1985 · 1,644 cites

Recent publications

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Annals of internal medicine · 1985 · 1,644 cites

Leading journals1

Annals of internal medicine1

Leading researchers7

Bennett JM1
Catovsky D1
Daniel MT1
Flandrin G1
Galton DA1
Gralnick HR1
Sultan C1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Identifiers

MeSHLeukemia, Erythroblastic, Acute

References & data sources

Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
Related entities are derived from literature co-mention (studied together) — associative, not causal.